Smith & Nephew PLC - Asset Resilience Ratio
Smith & Nephew PLC (SN) has an Asset Resilience Ratio of -0.69% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read SN total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1985–2023)
This chart shows how Smith & Nephew PLC's Asset Resilience Ratio has changed over time. See SN book value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Smith & Nephew PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Smith & Nephew PLC.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 0% |
| Short-term Investments | GBX-69.00 Million | -0.69% |
| Total Liquid Assets | GBX-69.00 Million | -0.69% |
Asset Resilience Insights
- Limited Liquidity: Smith & Nephew PLC maintains only -0.69% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Smith & Nephew PLC Industry Peers by Asset Resilience Ratio
Compare Smith & Nephew PLC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Beijing Wandong Medical Technology Co Ltd
SHG:600055 |
Medical Devices | 4.92% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
MODULIGHT OY EO 1
F:78W |
Medical Devices | 22.31% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.39% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Nova EYE Medical Ltd
AU:EYE |
Medical Devices | 11.08% |
Annual Asset Resilience Ratio for Smith & Nephew PLC (1985–2023)
The table below shows the annual Asset Resilience Ratio data for Smith & Nephew PLC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | -0.69% | GBX-69.00 Million ≈ $-8.40K |
GBX9.99 Billion ≈ $1.22 Million |
+0.98pp |
| 2021-12-31 | -1.67% | GBX-182.00 Million ≈ $-22.14K |
GBX10.92 Billion ≈ $1.33 Million |
-0.46pp |
| 2020-12-31 | -1.21% | GBX-133.00 Million ≈ $-16.18K |
GBX11.01 Billion ≈ $1.34 Million |
-0.07pp |
| 2019-12-31 | -1.14% | GBX-106.00 Million ≈ $-12.90K |
GBX9.30 Billion ≈ $1.13 Million |
+0.00pp |
| 2018-12-31 | -1.14% | GBX-92.00 Million ≈ $-11.19K |
GBX8.06 Billion ≈ $980.55K |
-0.35pp |
| 2017-12-31 | -0.79% | GBX-62.00 Million ≈ $-7.54K |
GBX7.87 Billion ≈ $957.06K |
-0.80pp |
| 2015-12-31 | 0.01% | GBX1.00 Million ≈ $121.67 |
GBX7.17 Billion ≈ $872.02K |
-2.95pp |
| 2012-12-31 | 2.96% | GBX167.00 Million ≈ $20.32K |
GBX5.64 Billion ≈ $686.47K |
-0.03pp |
| 2011-12-31 | 2.99% | GBX142.00 Million ≈ $17.28K |
GBX4.75 Billion ≈ $577.57K |
+2.68pp |
| 2009-12-31 | 0.31% | GBX14.00 Million ≈ $1.70K |
GBX4.57 Billion ≈ $555.43K |
-4.16pp |
| 2005-12-31 | 4.47% | GBX133.00 Million ≈ $16.18K |
GBX2.98 Billion ≈ $362.09K |
-2.12pp |
| 2004-12-31 | 6.59% | GBX192.27 Million ≈ $23.39K |
GBX2.92 Billion ≈ $355.22K |
-8.84pp |
| 2003-12-31 | 15.43% | GBX342.86 Million ≈ $41.72K |
GBX2.22 Billion ≈ $270.44K |
+15.33pp |
| 1995-12-31 | 0.10% | GBX1.24 Million ≈ $150.41 |
GBX1.27 Billion ≈ $154.82K |
-0.13pp |
| 1994-12-31 | 0.22% | GBX2.97 Million ≈ $361.42 |
GBX1.32 Billion ≈ $160.83K |
0.00pp |
| 1993-12-31 | 0.23% | GBX2.96 Million ≈ $359.95 |
GBX1.31 Billion ≈ $159.01K |
-0.77pp |
| 1991-12-31 | 0.99% | GBX15.72 Million ≈ $1.91K |
GBX1.58 Billion ≈ $192.56K |
-6.44pp |
| 1990-12-31 | 7.43% | GBX114.00 Million ≈ $13.87K |
GBX1.53 Billion ≈ $186.61K |
-1.81pp |
| 1989-12-31 | 9.24% | GBX125.00 Million ≈ $15.21K |
GBX1.35 Billion ≈ $164.62K |
+3.48pp |
| 1988-12-31 | 5.76% | GBX73.34 Million ≈ $8.92K |
GBX1.27 Billion ≈ $154.90K |
-2.86pp |
| 1987-12-31 | 8.62% | GBX105.86 Million ≈ $12.88K |
GBX1.23 Billion ≈ $149.34K |
+2.47pp |
| 1986-12-31 | 6.16% | GBX54.70 Million ≈ $6.66K |
GBX888.50 Million ≈ $108.10K |
-2.22pp |
| 1985-12-31 | 8.37% | GBX53.88 Million ≈ $6.56K |
GBX643.40 Million ≈ $78.28K |
-- |
About Smith & Nephew PLC
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; t… Read more